<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Early diagnosis represents the best opportunity for cure of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Current screening programmes use faecal occult blood testing for screening, which has limited sensitivity and poor specificity </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: In this study we looked at a series of previously described diagnostic markers utilising circulating free DNA (cfDNA), with a preparation method allowing small DNA fragments to be isolated </plain></SENT>
<SENT sid="3" pm="."><plain>The Circulating free DNA was isolated from samples obtained from 85 patients, including 35 patients without endoscopic abnormality, a group of 26 patients with benign colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath>, and 24 patients with colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>In each case, polymerase chain reaction (PCR) was performed for Line1 79 bp, Line1 300 bp, Alu 115 bp, Alu 247 bp, and <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> primers </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, carcinoembryonic antigen (CEA) was measured by ELISA </plain></SENT>
<SENT sid="6" pm="."><plain>Each marker was analysed between <z:mpath ids='MPATH_458'>normal</z:mpath>, <z:mpath ids='MPATH_491'>polyp</z:mpath>, and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> populations, and the best performing analysed in combination by logistic regression </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: The best model was able to discriminate <z:mpath ids='MPATH_458'>normal</z:mpath> from populations with <z:mpath ids='MPATH_270'>adenoma</z:mpath> or <z:mp ids='MP_0002038'>carcinoma</z:mp> using three DNA markers and CEA, showing an area under the receiver operator characteristic (ROC) curve of 0.855 with a positive predictive value of 81.1% for <z:mpath ids='MPATH_491'>polyps</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnosis </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: These circulating markers in combination with other markers offer the prospect of a simple blood test as a possible secondary screen for <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> and <z:mpath ids='MPATH_491'>polyps</z:mpath> in patients with positive faecal occult blood tests </plain></SENT>
</text></document>